Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase

British Journal of Pharmacology

Volumn 135, Issue 3, 2002, Pages 789-799

  Suenaga, Hiroshi ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Lysophosphatidylcholine; Rat aorta; Tyrosine kinase; adrenoceptor agonist

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CALCIUM ION; DAIDZEIN; GENISTEIN; LYSOPHOSPHATIDYLCHOLINE; PHORBOL ESTER; POTASSIUM ION; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN B 42; UNCLASSIFIED DRUG; VANADATE SODIUM;

ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

EID: 0036179764     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704525     Document Type: Article

References (48)

1. 2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle
2. Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCγ-1 and tyrosine kinase-Ras pathways
3. Vasoconstriction: A new activity for platelet-derived growth factor
4. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction
5. Angiotensin II signal transduction in vascular smooth muscle: Role of tyrosine kinases
6. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
7. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells
8. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart
9. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction
10. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity
11. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells
12. 2A receptor signal transduction
13. Evidence for selective inhibition by lysophosphatidylcholine of acetylcholine-induced endothelium-dependent hyperpolarization and relaxation in rat mesenteric artery
14. Effects of flavonoids on rat aortic smooth muscle contractility: Structure-activity relationships
15. Tyrosine kinase pathways and the regulation of smooth muscle contractility
16. Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle
17. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells
18. c-src in vascular smooth muscle cells
19. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
20. A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta
21. 2+ mobilization in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice
22. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats
23. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
24. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation
25. Regulation of vascular and gastric smooth muscle contractility by pervanadate
26. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists
27. 2+ sensitivity of vascular smooth muscle contraction
28. Plant derived estrogens relax rat mesenteric artery in vitro
29. Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells
30. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
31. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
32. Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura-2
33. Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling
34. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent elaxation in the pig coronary artery
35. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
36. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
37. 2+ in rat aorta
38. 2+ level and contraction on exposure of rat aorta to lysophosphatidylcholine
39. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C
40. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
41. Signal transduction by receptors with tyrosine kinase activity
42. Evidence that lysolecithin is an important causal agent of atherosclerosis
43. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase
44. Src tyrosine kinases and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases mediate pressure-induced c-fos expression in cannulated rat mesenteric small arteries
45. Effect of platelet-derived growth factor on voltage-operated calcium channels in rabbit isolated ear artery cells
46. Role of oxidized low density lipoprotein in atherogenesis
47. Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells
48. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein